Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2026-01-08 00:00:00 ET · period of report 2026-01-06 · accession 0001453687-26-000047 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-08 | 2026-01-06 | RNAC | Brunn Carsten | Pres, CEO, Dir | S - Sale | $6.82 | -23.8K | 323.5K | -7% | -$162.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-06 | S | D | 23,766 | $6.82 | 323,530 | D | — | — | (F1) Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees. |